Wave Life Sciences WVE Stock
Wave Life Sciences Price Chart
Wave Life Sciences WVE Financial and Trading Overview
| Wave Life Sciences stock price | 3.47 USD |
| Previous Close | 3.78 USD |
| Open | 3.81 USD |
| Bid | 4.27 USD x 200 |
| Ask | 7.5 USD x 200 |
| Day's Range | 3.71 - 3.88 USD |
| 52 Week Range | 3.56 - 21.73 USD |
| Volume | 3.5M USD |
| Avg. Volume | 3.08M USD |
| Market Cap | 738.93M USD |
| Beta (5Y Monthly) | -1.428 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.08 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 18.06 USD |
WVE Valuation Measures
| Enterprise Value | 291.92M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.239237 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 11.303647 |
| Price/Book (mrq) | 1.5984656 |
| Enterprise Value/Revenue | 4.466 |
| Enterprise Value/EBITDA | -1.361 |
Trading Information
Wave Life Sciences Stock Price History
| Beta (5Y Monthly) | -1.428 |
| 52-Week Change | -47.64% |
| S&P500 52-Week Change | 14.57% |
| 52 Week High | 21.73 USD |
| 52 Week Low | 3.56 USD |
| 50-Day Moving Average | 4.96 USD |
| 200-Day Moving Average | 8.69 USD |
WVE Share Statistics
| Avg. Volume (3 month) | 3.08M USD |
| Avg. Daily Volume (10-Days) | 3.58M USD |
| Shares Outstanding | 197.05M |
| Float | 94.57M |
| Short Ratio | 5.45 |
| % Held by Insiders | 15.50% |
| % Held by Institutions | 85.37% |
| Shares Short | 17.64M |
| Short % of Float | 11.03% |
| Short % of Shares Outstanding | 8.94% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3248.32% |
| Gross Margin | -202.0010% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -33.60% |
| Return on Equity (ttm) | -67.41% |
Income Statement
| Revenue (ttm) | 65.37M USD |
| Revenue Per Share (ttm) | 0.35 USD |
| Quarterly Revenue Growth (yoy) | -73.90% |
| Gross Profit (ttm) | -132050000 USD |
| EBITDA | -214520000 USD |
| Net Income Avi to Common (ttm) | -202472992 USD |
| Diluted EPS (ttm) | -1.08 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 490.6M USD |
| Total Cash Per Share (mrq) | 2.49 USD |
| Total Debt (mrq) | 43.59M USD |
| Total Debt/Equity (mrq) | 9.61 USD |
| Current Ratio (mrq) | 9.987 |
| Book Value Per Share (mrq) | 2.346 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -191576992 USD |
| Levered Free Cash Flow (ttm) | -128778376 USD |
Profile of Wave Life Sciences
| Country | United States |
| State | MA |
| City | Cambridge |
| Address | 733 Concord Avenue |
| ZIP | 02138 |
| Phone | 617 949 2900 |
| Website | https://wavelifesciences.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 317 |
Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs; and clinical programs for Duchenne muscular dystrophy and Huntington's disease, as well as various preclinical programs utilizing its RNA medicines platform. Wave Life Sciences, Inc. was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Q&A For Wave Life Sciences Stock
What is a current WVE stock price?
Wave Life Sciences WVE stock price today per share is 3.47 USD.
How to purchase Wave Life Sciences stock?
You can buy WVE shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Wave Life Sciences?
The stock symbol or ticker of Wave Life Sciences is WVE.
Which industry does the Wave Life Sciences company belong to?
The Wave Life Sciences industry is Biotechnology.
How many shares does Wave Life Sciences have in circulation?
The max supply of Wave Life Sciences shares is 197.05M.
What is Wave Life Sciences Price to Earnings Ratio (PE Ratio)?
Wave Life Sciences PE Ratio is now.
What was Wave Life Sciences earnings per share over the trailing 12 months (TTM)?
Wave Life Sciences EPS is -1.08 USD over the trailing 12 months.
Which sector does the Wave Life Sciences company belong to?
The Wave Life Sciences sector is Healthcare.
Wave Life Sciences WVE included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
27193.34 USD — |
-1.25
|
7.7B USD — | 27066.76 USD — | 27491.9 USD — | — - | 7.7B USD — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
4000.62 USD — |
-1.26
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
|
US Tech Global Market Composite
NQGM
US
|
2102.22 USD — |
-0.89
|
— — | 2081.46 USD — | 2103.72 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
6803.34 USD — |
-1.1
|
— — | 6678.62 USD — | 6820.47 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1285.8 USD — |
-0.77
|
— — | 1265.56 USD — | 1286.72 USD — | — - | — — |
- {{ link.label }} {{link}}
